Endoplasmatic reticulum aminopeptidase 1 (ERAP1) is a multifunctional enzyme involved in trimming of peptides to an optimal length for presentation by major histocompatibility complex (MHC) class I molecules. Polymorphisms in ERAP1 have been associated with chronic inflammatory diseases, including ankylosing spondylitis (AS) and psoriasis, and subsequent in vitro enzyme studies suggest distinct catalytic properties of ERAP1 variants. To understand structure-activity relationships of this enzyme we determined crystal structures in open and closed states of human ERAP1, which provide the first snapshots along a catalytic path. ERAP1 is a zinc-metallopeptidase with typical H-E-X-X-H-(X)(18)-E zinc binding and G-A-M-E-N motifs characteristic for members of the gluzincin protease family. The structures reveal extensive domain movements, including an active site closure as well as three different open conformations, thus providing insights into the catalytic cycle. A K(528)R mutant strongly associated with AS in GWAS studies shows significantly altered peptide processing characteristics, which are possibly related to impaired interdomain interactions.
Proc Natl Acad Sci U S A
7745 - 7750
Amino Acid Sequence, Amino Acid Substitution, Aminopeptidases, Antigen Presentation, Catalytic Domain, Crystallography, X-Ray, HLA-B27 Antigen, Humans, Minor Histocompatibility Antigens, Models, Molecular, Mutagenesis, Site-Directed, Polymorphism, Single Nucleotide, Protein Conformation, Protein Processing, Post-Translational, Protein Structure, Tertiary, Recombinant Proteins, Spondylitis, Ankylosing